ID   SPHK2_HUMAN             Reviewed;         654 AA.
AC   Q9NRA0; A0T4C8; B4DU87; Q9BRN1; Q9H0Q2; Q9NWU7;
DT   24-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-JUL-2002, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Sphingosine kinase 2;
DE            Short=SK 2;
DE            Short=SPK 2;
DE            EC=2.7.1.91 {ECO:0000269|PubMed:10751414};
GN   Name=SPHK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=10751414; DOI=10.1074/jbc.M002759200;
RA   Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S.,
RA   Milstien S., Kohama T., Spiegel S.;
RT   "Molecular cloning and functional characterization of a novel
RT   mammalian sphingosine kinase type 2 isoform.";
RL   J. Biol. Chem. 275:19513-19520(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Alemany R., Ruemenapp U., van Koppen C.J., Danneberg K.,
RA   Meyer zu Heringdorf D., Jakobs K.H.;
RT   "Variant of human sphingosine kinase-2 (SPHK2).";
RL   Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-354 (ISOFORM 3).
RC   TISSUE=Carcinoma, and Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Placenta;
RX   PubMed=17897319; DOI=10.1111/j.1600-0854.2007.00643.x;
RA   Schroeder B., Wrocklage C., Pan C., Jaeger R., Koesters B.,
RA   Schaefer H., Elsaesser H.-P., Mann M., Hasilik A.;
RT   "Integral and associated lysosomal membrane proteins.";
RL   Traffic 8:1676-1686(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND REGION.
RX   PubMed=19168031; DOI=10.1016/j.bbrc.2009.01.075;
RA   Don A.S., Rosen H.;
RT   "A lipid binding domain in sphingosine kinase 2.";
RL   Biochem. Biophys. Res. Commun. 380:87-92(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387 AND SER-399, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-477, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the phosphorylation of sphingosine to form
CC       sphingosine 1-phosphate (SPP), a lipid mediator with both intra-
CC       and extracellular functions. Also acts on D-erythro-
CC       dihydrosphingosine, D-erythro-sphingosine and L-threo-
CC       dihydrosphingosine. Binds phosphoinositides.
CC       {ECO:0000269|PubMed:19168031}.
CC   -!- CATALYTIC ACTIVITY: ATP + a sphingoid base = ADP + a sphingoid
CC       base 1-phosphate. {ECO:0000269|PubMed:10751414}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by sulfatide.
CC       {ECO:0000269|PubMed:19168031}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.4 uM for sphingosine {ECO:0000269|PubMed:10751414};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:10751414};
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Lysosome membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q9NRA0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRA0-2; Sequence=VSP_006217;
CC       Name=3;
CC         IsoId=Q9NRA0-3; Sequence=VSP_006217, VSP_006218;
CC       Name=4;
CC         IsoId=Q9NRA0-4; Sequence=VSP_046910;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9NRA0-5; Sequence=VSP_047721, VSP_047722;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF245447; AAF74124.1; -; mRNA.
DR   EMBL; EF107108; ABK81123.1; -; mRNA.
DR   EMBL; AL136701; CAB66636.1; -; mRNA.
DR   EMBL; AK000599; BAA91280.1; -; mRNA.
DR   EMBL; AK300541; BAG62249.1; -; mRNA.
DR   EMBL; AC022154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006161; AAH06161.1; -; mRNA.
DR   EMBL; BC010671; AAH10671.1; -; mRNA.
DR   CCDS; CCDS12727.1; -. [Q9NRA0-1]
DR   CCDS; CCDS59404.1; -. [Q9NRA0-4]
DR   CCDS; CCDS59405.1; -. [Q9NRA0-2]
DR   RefSeq; NP_001191087.1; NM_001204158.2. [Q9NRA0-4]
DR   RefSeq; NP_001191088.1; NM_001204159.2. [Q9NRA0-1]
DR   RefSeq; NP_001191089.1; NM_001204160.2. [Q9NRA0-2]
DR   RefSeq; NP_064511.2; NM_020126.4. [Q9NRA0-1]
DR   RefSeq; XP_006723355.1; XM_006723292.1. [Q9NRA0-2]
DR   RefSeq; XP_011525435.1; XM_011527133.1. [Q9NRA0-1]
DR   RefSeq; XP_011525436.1; XM_011527134.1. [Q9NRA0-2]
DR   UniGene; Hs.528006; -.
DR   ProteinModelPortal; Q9NRA0; -.
DR   SMR; Q9NRA0; -.
DR   BioGrid; 121208; 3.
DR   IntAct; Q9NRA0; 5.
DR   STRING; 9606.ENSP00000245222; -.
DR   BindingDB; Q9NRA0; -.
DR   ChEMBL; CHEMBL3023; -.
DR   GuidetoPHARMACOLOGY; 2205; -.
DR   SwissLipids; SLP:000000112; -.
DR   iPTMnet; Q9NRA0; -.
DR   PhosphoSitePlus; Q9NRA0; -.
DR   BioMuta; SPHK2; -.
DR   DMDM; 22001996; -.
DR   EPD; Q9NRA0; -.
DR   MaxQB; Q9NRA0; -.
DR   PaxDb; Q9NRA0; -.
DR   PeptideAtlas; Q9NRA0; -.
DR   PRIDE; Q9NRA0; -.
DR   DNASU; 56848; -.
DR   Ensembl; ENST00000245222; ENSP00000245222; ENSG00000063176. [Q9NRA0-1]
DR   Ensembl; ENST00000598088; ENSP00000469158; ENSG00000063176. [Q9NRA0-1]
DR   Ensembl; ENST00000599748; ENSP00000471205; ENSG00000063176. [Q9NRA0-2]
DR   Ensembl; ENST00000600537; ENSP00000470092; ENSG00000063176. [Q9NRA0-4]
DR   GeneID; 56848; -.
DR   KEGG; hsa:56848; -.
DR   UCSC; uc002pjr.4; human. [Q9NRA0-1]
DR   CTD; 56848; -.
DR   DisGeNET; 56848; -.
DR   GeneCards; SPHK2; -.
DR   HGNC; HGNC:18859; SPHK2.
DR   HPA; HPA065508; -.
DR   MIM; 607092; gene.
DR   neXtProt; NX_Q9NRA0; -.
DR   OpenTargets; ENSG00000063176; -.
DR   PharmGKB; PA38719; -.
DR   eggNOG; KOG1116; Eukaryota.
DR   eggNOG; COG1597; LUCA.
DR   GeneTree; ENSGT00690000101761; -.
DR   HOGENOM; HOG000111460; -.
DR   HOVERGEN; HBG054796; -.
DR   InParanoid; Q9NRA0; -.
DR   KO; K04718; -.
DR   PhylomeDB; Q9NRA0; -.
DR   TreeFam; TF354296; -.
DR   BRENDA; 2.7.1.91; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   SIGNOR; Q9NRA0; -.
DR   ChiTaRS; SPHK2; human.
DR   GeneWiki; SPHK2; -.
DR   GenomeRNAi; 56848; -.
DR   PRO; PR:Q9NRA0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000063176; -.
DR   ExpressionAtlas; Q9NRA0; baseline and differential.
DR   Genevisible; Q9NRA0; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017050; F:D-erythro-sphingosine kinase activity; TAS:Reactome.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0017016; F:Ras GTPase binding; NAS:UniProtKB.
DR   GO; GO:0008481; F:sphinganine kinase activity; TAS:Reactome.
DR   GO; GO:0038036; F:sphingosine-1-phosphate receptor activity; IMP:UniProtKB.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006669; P:sphinganine-1-phosphate biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   GO; GO:0046512; P:sphingosine biosynthetic process; IMP:UniProtKB.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SUPFAM; SSF111331; SSF111331; 2.
DR   PROSITE; PS50146; DAGK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Lysosome; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    654       Sphingosine kinase 2.
FT                                /FTId=PRO_0000181358.
FT   DOMAIN      178    325       DAGKc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     188    190       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     220    224       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     277    279       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     622    624       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   REGION        1    175       Required for binding to sulfatide and
FT                                phosphoinositides and for membrane
FT                                localization.
FT   REGION      245    248       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    247    247       Proton donor/acceptor. {ECO:0000250}.
FT   BINDING     252    252       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   BINDING     344    344       Substrate. {ECO:0000250}.
FT   BINDING     351    351       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   BINDING     357    357       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   MOD_RES     387    387       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JIA7}.
FT   MOD_RES     399    399       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     477    477       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     36       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10751414,
FT                                ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006217.
FT   VAR_SEQ       1     12       MNGHLEAEEQQD -> MIGCLHARVSGPLWDAGLCPASSRS
FT                                AHTCLSLSVSDAPVSPATAPHCLLLSTAPAPPCPCHGVLNS
FT                                HPFSPPFP (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047721.
FT   VAR_SEQ      13     71       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046910.
FT   VAR_SEQ     292    390       FEPALGLDLLLNCSLLLCRGGGHPLDLLSVTLASGSRCFSF
FT                                LSVAWGFVSDVDIQSERFRALGSARFTLGTVLGLATLHTYR
FT                                GRLSYLPATVEPASPTP -> PREDSDSSTSSSACPLWTTA
FT                                RSCPRAAASMPGSCPLLPQQLALGFSRFIQDRVNGGGGRIG
FT                                SLTCRGHTQRTLPAPAREGGGSLFLKNINVFICKKKKK
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_006218.
FT   VAR_SEQ     640    654       GTLLTGPPGCPGREP -> ARGRTQTPALPAAPALYGRQPG
FT                                AAHGLQPVCQGAALFFHNSWLWGSQDLFRIVLTEAVGG
FT                                (in isoform 5). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047722.
FT   VARIANT     652    652       R -> Q (in dbSNP:rs11881285).
FT                                /FTId=VAR_060112.
FT   CONFLICT     49     49       P -> S (in Ref. 3; CAB66636).
FT                                {ECO:0000305}.
SQ   SEQUENCE   654 AA;  69217 MW;  F73FFCEC930DA50F CRC64;
     MNGHLEAEEQ QDQRPDQELT GSWGHGPRST LVRAKAMAPP PPPLAASTPL LHGEFGSYPA
     RGPRFALTLT SQALHIQRLR PKPEARPRGG LVPLAEVSGC CTLRSRSPSD SAAYFCIYTY
     PRGRRGARRR ATRTFRADGA ATYEENRAEA QRWATALTCL LRGLPLPGDG EITPDLLPRP
     PRLLLLVNPF GGRGLAWQWC KNHVLPMISE AGLSFNLIQT ERQNHARELV QGLSLSEWDG
     IVTVSGDGLL HEVLNGLLDR PDWEEAVKMP VGILPCGSGN ALAGAVNQHG GFEPALGLDL
     LLNCSLLLCR GGGHPLDLLS VTLASGSRCF SFLSVAWGFV SDVDIQSERF RALGSARFTL
     GTVLGLATLH TYRGRLSYLP ATVEPASPTP AHSLPRAKSE LTLTPDPAPP MAHSPLHRSV
     SDLPLPLPQP ALASPGSPEP LPILSLNGGG PELAGDWGGA GDAPLSPDPL LSSPPGSPKA
     ALHSPVSEGA PVIPPSSGLP LPTPDARVGA STCGPPDHLL PPLGTPLPPD WVTLEGDFVL
     MLAISPSHLG ADLVAAPHAR FDDGLVHLCW VRSGISRAAL LRLFLAMERG SHFSLGCPQL
     GYAAARAFRL EPLTPRGVLT VDGEQVEYGP LQAQMHPGIG TLLTGPPGCP GREP
//
